Malin Corp. PLC appointed Andrew von Eschenbach to serve as chief medical adviser.
Von Eschenbach was previously an advisory partner to Malin. He served as the commissioner of the U.S. Food and Drug Administration from 2006 to 2009. Prior to that, he was the director of the National Cancer Institute at the National Institute of Health.
Von Eschenbach is the president of Samaritan Health Initiatives Inc.